VAERS reports by lot

Pfizer COVID-19 lot E10140: VAERS reports

41 VAERS reports list lot E10140 as a Pfizer COVID-19 vaccine, received between 2020-12-21 and 2021-10-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
41
Reports
15%
Marked serious
5
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5627%
Cardiac / Cardiovascular5124%
Gastrointestinal3014%
Neurological2010%
Respiratory126%
Musculoskeletal126%
Injection-site / Local reaction94%
Allergic / Anaphylactic73%
Dermatological (non-injection-site)63%
Psychiatric / Neuropsychiatric42%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York15
California4
Kentucky4
Georgia3
Pennsylvania2
Ohio2
New Jersey1
Idaho1
Maryland1
Michigan1
Texas1
Maine1

Reports by month received

2020-125
2021-0121
2021-026
2021-046
2021-081
2021-091
2021-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.